Resources
- sort by:
- Relevance
- Date
- Popularity
- Dendrite Sells First ForcePharma to Pfizer Australia
- MORRISTOWN, N.J.--BUSINESS WIRE--October 23, 1998--Dendrite International, Inc. (NASDAQ/NMS:DRTE), the leading supplier of enterprise-wide sales force effectiveness solutions for the Pharmaceutical and Consumer Packaged Goods CPG industries announced today, Pfizer Australia has signed an agreement to upgrade their current ETMS with ForcePharma - a new generation system of sales enterprise products...
- Research articles 1998-10-23
- PFIZER INC - Statement re: Pfizer Lipitor patent in Australia.
- Australian Federal Court Upholds Basic Lipitor Patent, Preventing Launch of Generic Ranbaxy Product ...
- Research articles 2006-12-20
- Pfizer/IOC Olympic Research Results Revealed At Sixth IOC Olympic World Congress On Sport Sciences
- The International Olympic Committee IOC and Pfizer announced findings from the Pfizer/IOC Olympic Research on Sport Sciences conducted at the 2000 Olympic Summer Games in Sydney, Australia and the 2002 Olympic Winter Games in Salt Lake City at the Sixth IOC Olympic World Congress on Sport Sciences.The Pfizer/IOC Olympic Research...
- Research articles 1970-01-01
- AUSTRALIA'S CSL TO SELL ANIMAL HEALTH BUSINESS TO PFIZER.
- SYDNEY, Dec 16 Asia Pulse - Blood products company CSL Ltd (ASX:CSL) has reached an agreement to sell its animal health business to one of the world's largest health companies, New York-based Pfizer Inc. SYDNEY, Dec 16 Asia Pulse - Blood products company CSL...
- Research articles 2003-12-16
- pSivida Receives First R&D Payments from Pfizer
- BOSTON & PERTH, Australia -- pSivida Limited (NASDAQ:PSDV)(ASX:PSD)(Xetra:PSI) today announced the receipt of US$500k as the first quarterly research and development payment from Pfizer under the terms of the exclusive worldwide Collaborative Research and License Agreement signed in April 2007 for pSivida's controlled drug delivery technologies in ophthalmic applications.
- Research articles 2008-02-20
- pSivida Signs $165 Million Collaborative Research and Licensing Agreement with Pfizer
- BOSTON & PERTH, Australia -- pSivida Limited (NASDAQ:PSDV)(ASX:PSD)(Xetra:PSI), today announced it has signed an exclusive worldwide Collaborative Research and License Agreement with Pfizer Inc. (NYSE: PFE) for pSivida's controlled drug delivery technologies, including the MedidurTM technology, in ophthalmic applications.
- Research articles 2007-04-04
- FDA Calendar Updates: Medivation, Pfizer, AstraZeneca
- Mike Havrilla submits: Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of 288 entries as of 7/30/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA....
- External links 2009-07-30
- Dendrite Successfully Implements ForcePharma With Pfizer Australia
- MORRISTOWN, N.J.--BUSINESS WIRE--July 20, 1999--
- Research articles 1999-07-20
- Need to know: Electrolux cut ... Merck consent ... Cape success
- View video and Need to Know interactive heatmap Economics UK economy: Britain is now in the grip of the longest recession on record, according to official data. The economy shrank 0.4 per cent between July and September, its sixth consecutive quarterly decline. Output has fallen 5.9 per cent since the...
- News items 2009-10-23
- CIL debuts Auburn.
- May 15, 2002 Packaging News ABIX via COMTEX -- A factory in Auburn, Sydney New South Wales was launched by Cumberland Industries. The contract packaging group has GE Lighting Australia, Faber-Castell, Goodman Fielder, Laboratories Pharmacare, the Commonwealth Bank of Australia, Pfizer, McDonald's Australia...
- Research articles 2002-05-23
- Meares Taine takes on Sydney.
- Feb 15, 2002 Ad News ABIX via COMTEX -- Meares Taine is an advertising agency in New Zealand. It is powered by the two creatives, Roy Meares and Jeremy Taine. In early 2002, this agency is expanding into Australia. It has now set up...
- Research articles 2002-02-27
- Celgene Corp. Q3 2008 Earnings Conference Call Transcript
- Question-and-Answer SessionThank you. [Operator Instructions]. We'll go first to Katherine Kim with Banc of America Securities. Katherine Kim - Banc of America Securities Hi. I have several questions. The first is for David. Can you just talk about the Pfizer royalty stream that you brought back. What is effect...
- Earnings calls 2008-10-23
- R&D blueprint fails to impress.
- Sep 11, 2001 The Australian Financial Review ABIX via COMTEX -- The Australian Senate is holding an inquiry into the Government's research and development (R&D) blueprint. The innovation statement issued by the Government in January 2001 has attracted criticism from firms and business groups...
- Research articles 2001-09-10
- pSivida Announces Closing of Second Tranche of Offering of American Depositary Shares and Warrants
- pSivida Also Closes Related Offering of Ordinary Shares BOSTON & PERTH, Australia -- pSivida Limited (NASDAQ:PSDV)(ASX:PSD)(Xetra:PSI) today announced that it closed the second tranche of its previously reported registered direct offering. The second part of the closing related to the sale of 5,200,000 units at a price of US$1.25...
- Research articles 2007-07-16
- pSivida Quarterly Cash Flow - March 31, 2008 Commentary and Highlights
- - Reincorporation Plan Announced - Medidur Collaboration Agreement Amended - BrachySil Pancreatic Cancer Phase IIa Results - Pfizer R&D Quarterly Payments Commence BOSTON, MA. & PERTH, Australia -- pSivida Limited (NASDAQ: PSDV)(ASX: PSD)(FSE: PSI) announced the filing of its Quarterly Cash Flow Statement for the quarter...
- Research articles 2008-04-30
- Artemis Surpasses 600,000 Users Worldwide; Company Adds 30 New Customers in First Half 2005
- NEWPORT BEACH, Calif. -- Artemis International Solutions Corporation (OTCBB:AMSI), global provider of Investment Planning and ControlTM solutions, has surpassed the 600,000 worldwide user mark with 30 new customers signed in first half 2005. The most recent additions to the already impressive list of customers include France Telecom, Pfizer, Hitachi, Raytheon,...
- Research articles 2005-10-17
- Timid innovators dip a toe.
- Oct 16, 2003 (BRW - ABIX via COMTEX) There are few innovative new products in Australia. Many companies feel safer sticking to the same products or changing the packaging. Nevertheless, there have been some innovative new products in 2003. The best examples include Virgin...
- Research articles 2003-10-22
- FAIRFAX ADMEDIA AGENCY OF THE YEAR AWARDS
- Sweet smell of sucess Colenso BBDO Real growth from existing clients and record new- business growth were at the heart of Colenso's win this year. The agency increased billings in 2004 by 10% (the judges saw the numbers but AdMedia is unable, thanks to America's stifling...
- Research articles 2005-03-17
- Growth in the USA.
- Jun 17, 2003 (Independent Financial Advisor - ABIX via COMTEX) The AXA Australia US Equity Premier Growth Fund is managed for AXA by the US-based Alliance Capital. Currently, there is around $A3.9 million invested in the fund. The Alliance US Equity Premier Growth Fund,...
- Research articles 2003-06-17
- << Previous
- page 1 of 1
- Next >>
